论文信息 - Degeneracy instead of specificity: is this a solution to cancer immunotherapy? - 字舞流文

Degeneracy instead of specificity: is this a solution to cancer immunotherapy?

Joachim L Schultze | J. Schultze

[1] H. Eisen,et al. Specificity and degeneracy in antigen recognition: yin and yang in the immune system. , 2001, Annual review of immunology.

[2] G. Ogg,et al. Ex Vivo Staining of Metastatic Lymph Nodes by Class I Major Histocompatibility Complex Tetramers Reveals High Numbers of Antigen-experienced Tumor-specific Cytolytic T Lymphocytes , 1998, The Journal of experimental medicine.

[3] D. Hafler. Degeneracy, as opposed to specificity, in immunotherapy. , 2002, The Journal of clinical investigation.

[4] D. Speiser,et al. Melan-A/MART-1-specific CD8 T cells: from thymus to tumor. , 2002, Trends in immunology.

[5] Danila Valmori,et al. Thymic Selection Generates a Large T Cell Pool Recognizing a Self-Peptide in Humans , 2002, The Journal of experimental medicine.

[6] J. Renauld,et al. A new gene coding for a differentiation antigen recognized by autologous cytolytic T lymphocytes on HLA-A2 melanomas , 1994, The Journal of experimental medicine.